JP
John Paulson (Paulson & Co) disclosed reduced in THRYV HLDGS INC
John Paulson (Paulson & Co) filed a 13F change in THRYV HLDGS INC (886029206) on 2026-05-15, covering period end 2026-03-31.
Action
Reduced
Capital
$23,136,108 current disclosed value
Institutional 13F Signals1 evidence source
Why it matters
This signal is selected by portfolio impact within the manager filing, while the full filing change list remains available in the briefing.
Full Filing Changes
10 changes from John Paulson (Paulson & Co), filed 2026-05-15 for period end 2026-03-31.
$3.1B portfolio value
| Stock | Action | Change | Current | Portfolio Impact |
|---|---|---|---|---|
558868105 MADRIGAL PHARMACEUTICALS INC | Reduced | -$265.6M | $728.8M | 8.54% |
714266103 PERPETUA RESOURCES CORP | Increased | $126.5M | $909.6M | 4.06% |
71734107 BAUSCH HEALTH COS INC | Reduced | -$113.5M | $395.6M | 3.65% |
46050R102 INTERNATIONAL TOWER HILL MIN | Increased | $98.4M | $229.0M | 3.16% |
83443Q103 SOLSTICE ADVANCED MATLS INC | Sold out | -$67.8M | $0 | 2.18% |
10948W103 ACADIAN ASSET MANAGEMENT INC | Increased | $57.5M | $421.4M | 1.85% |
8474108 AGNICO EAGLE MINES LTD | Increased | $26.2M | $159.0M | 0.84% |
6.6987E+210 NOVAGOLD RESOURCES INC | Reduced | -$9.3M | $244.6M | 0.30% |
886029206 THRYV HLDGS INC | Reduced | -$3.2M | $23.1M | 0.10% |
03152W109 AMICUS THERAPEUTIC | New | $468,504 | $468,504 | 0.02% |